Menarini Benelux NV/SA - Division Diagnostics

A.Menarini Diagnostics will be attending the 19th Molecular Diagnostics in Pathology meeting on January 31st at the Van der Valk Hotel, Utrecht. We will be showcasing our innovative and non-invasive biomarker test for primary and recurrent bladder cancer. We look forward to meeting you and discussing how our solutions can help improve patient care in urology. #menarini #urology #healthcare #bladdercancer

Empowering European Laboratories with Flash10 and Nano: Our New Partnership with Coyote Bioscience We are excited to announce our collaboration with Coyote Bioscience Co. Ltd. to distribute across major European countries their Flash10 and Nano diagnostic instruments for Molecular Diagnostics Point Of Care routines. As the largest distributor of diagnostic solutions in Europe, A.Menarini Diagnostics is committed to providing advanced, automated, and flexible solutions to laboratories across the region. Flash10 and Nano will enable faster, more accurate molecular diagnostics, improving workflows and meeting the growing demands of #healthcare.  "We are extremely happy to complement our Molecular Diagnostics portfolio with the Flash Detect Flash10 and Nano” said Fabio Piazzalunga, General Manager and Global Head of Diagnostics. "Our goal is to make molecular diagnostics more accessible and efficient and become the partner of choice for laboratories of all sizes, from high-volume environments to those with limited resources." #innovation #technology #moleculardiagnostics

✨ We’re thrilled to be partnering with Sinocare at "Les Rencontres de Diabétologie"! ✨ A big congratulations to the organizers (l'association du diabète) for hosting such a great event that brings together experts and innovators in the field of diabetes care. It’s a privilege to be part of this important gathering. Our collaboration with Sinocare continues to drive advancements in diabetes management, and we’re excited to showcase our innovative diagnostic solutions at this fantastic event. Looking forward to the fruitful discussions and insights that will emerge over the coming days! 💪 👌 #MenariniDiagnostics #Sinocare #DiabetesCare #HealthcareInnovation #LesRencontresDeDiabétologie #PartnershipForHealth

Want to learn more about non-muscle invasive bladder cancer (NIMBC) surveillance and the role of biomarkers? Watch this video of an expert discussing the benefits of urinary biomarkers in NMIBC surveillance https://lnkd.in/dHP8G6Hy #bladdercancer #surveillance #urinebiomarkers

Distribution Agreement for new 3rd Generation CGM System We are pleased to announce an exclusive Distribution Agreement between A. Menarini Diagnostics and Sinocare for the promotion of a new third generation Continuous Glucose Monitoring (CGM) system in more than 20 jurisdictions in Europe. This strategic partnership is a significant milestone in our commitment to providing innovative and reliable healthcare solutions to improve the quality of life of people with diabetes. For more info please check our website https://lnkd.in/deSFTVbM #Menarini #Sinocare #CGM #innovation #diagnostics #healthcare

Do you have 11 minutes? Take advantage of it to watch the episode dedicated to fat particles from the webinar series "The Particles of the Urinary Sediment and their Clinical Meaning" in Pills. Join us for a quick, insightful look into how these particles impact clinical diagnostics. Watch now to deepen your understanding in just a few minutes! Visit the link: https://lnkd.in/dERB5gcs #urinarysediment #phasecontrast #urinalysis #technology #healthcare #laboratoryn #innovation

Don't miss the opportunity to learn from experts about one of the most critical topics in healthcare today September 11th at 6 p.m.: Antimicrobial Resistance (AMR), a growing public health priority. The pediatric setting presents unique challenges, making the management of antibiotic therapy particularly complex.  This webinar will explore how accurate diagnosis plays a crucial role in guiding the selection of the most appropriate treatment. Click here to join the free webinar:  https://lnkd.in/drq4znNU #innovation #amr

A. Menarini Diagnostics and Nucleix Ltd. announce a strategic partnership for a non-invasive bladder cancer test in Europe. Read the full release https://lnkd.in/dvCV7bJm #bladdercancer #liquidbiopsy #noninvasivetest #innovation

We are thrilled to announce that A. Menarini Diagnostics will be participating in the 36th European Congress of Pathology (ECP)! Join us at this premier event where we will be showcasing our latest innovative solutions in the field of pathology.  Date: 7 - 11 September 2024  Location: Florence  Booth: #21 We look forward to connecting with industry professionals and sharing our advancements. See you there! #ECP2024 #Pathology #Innovation #Healthcare #menarini